Want to see MTD full AI Analyst Report?
Top Page
Mettler-Toledo
(NYSE:MTD)
Select Model
Select Model
Rating:75Outperform
Price Target:
$1,626.00
▲(22.52% Upside)
Action:Reiterated
Date:08/04/26
The score is driven primarily by strong underlying financial performance (high margins and free-cash-flow strength) and a positive earnings update with raised guidance. Offsetting factors are balance-sheet leverage/negative equity history, stretched technical conditions after a strong run, and a premium valuation (P/E ~31.8) without a stated dividend yield.
Positive Factors
High and Stable Margins
Sustained high gross and operating margins indicate durable pricing power and cost structure advantages across lab, industrial and inspection products. This margin profile supports reinvestment in R&D, funds service expansion, and provides a cushion versus cyclical revenue swings, preserving long-term profitability.
Negative Factors
Meaningful Leverage and Equity Volatility
Material debt levels and a recent history of negative or very low equity constrain balance-sheet flexibility and increase refinancing and interest-rate risk. In downturns this leverage can limit strategic choices (capex, acquisitions, buybacks) and amplify returns volatility despite strong operations.
Read all positive and negative factors
Positive Factors
Negative Factors
High and Stable Margins
Sustained high gross and operating margins indicate durable pricing power and cost structure advantages across lab, industrial and inspection products. This margin profile supports reinvestment in R&D, funds service expansion, and provides a cushion versus cyclical revenue swings, preserving long-term profitability.
Read all positive factors
Mettler-Toledo Key Performance Indicators (KPIs)
Any
Revenue By Segment
Analyzes income from different business segments, highlighting which areas drive growth and profitability, and where the company might be vulnerable or have expansion opportunities.
Analyzes income from different business segments, highlighting which areas drive growth and profitability, and where the company might be vulnerable or have expansion opportunities.
Data provided by:
The Fly
The FlyMettler-Toledo (MTD) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$28.62B
Dividend YieldN/A
Average Volume (3M)196.55K
Price to Earnings (P/E)31.8
Beta (1Y)0.89
Revenue Growth6.91%
EPS Growth12.43%
CountryUS
Employees18,100
SectorHealthcare
Sector Strength45
IndustryMedical - Diagnostics & Research
Share Statistics
EPS (TTM)44.54
Shares Outstanding20,207,602
10 Day Avg. Volume168,163
30 Day Avg. Volume196,546
Financial Highlights & Ratios
PEG Ratio8.96
Price to Book (P/B)-1.22K
Price to Sales (P/S)7.14
P/FCF Ratio33.86
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$1,424.45Price Target Upside7.33% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
EPS Forecast (FY)47.28
Revenue Forecast (FY)$4.24B
Mettler-Toledo Business Overview & Revenue Model
Company Description
Mettler-Toledo International Inc. (MTD) is a global enterprise dedicated to the production and provision of precision instruments and related services. The company's operations are strategically organized across five geographical divisions: its do...
How the Company Makes Money
Mettler-Toledo primarily makes money by selling hardware instruments and related solutions, supplemented by recurring revenue from services and consumables.
Key revenue streams:
1) Instrument and system sales (core): The largest portion of revenu...
Mettler-Toledo Earnings Call Summary
Earnings Call Date:Jul 30, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Nov 05, 2026
Earnings Call Sentiment Positive
The call conveyed a decidedly positive operational and financial picture: revenue growth beat expectations, margins expanded, adjusted EPS rose ~14% and full-year guidance was raised. Strength was broad-based (China, emerging markets, Lab, Industrial automation, services) and driven by pricing, productivity initiatives (Spinnaker) and product innovation. Notable risks and noise included one-time tariff refund accounting that reduced reported sales, timing-related weakness in Product Inspection and certain projects, EU chemical exposure to energy costs, higher transportation costs, and short backlog that increases near-term sensitivity. On balance, management presented confidence in execution and raised guidance, indicating momentum into the second half despite identifiable near-term risks.Positive Updates
Top-Line Growth Outperformed Expectations
Q2 sales were $1.0B, up 7% in USD and 6% in local currency; organic local-currency sales growth was 4% and acquisitions contributed ~1.5%.
Negative Updates
Tariff Refunds Created One-Time Accounting Noise and Reduced Reported Sales
A one-time gross benefit of $52M from IEEPA tariff refunds benefited cost of sales but was partially offset by a $28M refund to customers that reduced reported net sales by ~3%; the company excludes these items from adjusted results.
Read all updates
Q2-2026 Updates
Positive
Negative
Top-Line Growth Outperformed Expectations
Q2 sales were $1.0B, up 7% in USD and 6% in local currency; organic local-currency sales growth was 4% and acquisitions contributed ~1.5%.
Read all positive updates
Company Guidance
The company raised its full‑year 2026 guidance, now calling for local‑currency sales growth of approximately 4%–5% (organic 3%–4%) excluding the one‑time tariff refunds, with adjusted EPS guidance of $47.15–$47.50 (up ~10%–11%, or ~11%–12% excluding currency); at recent spot rates FX is estimated to be a ~1% benefit to sales and a slight headwind to EPS. For Q3 2026 the company expects local‑currency sales growth of ~4% (including ~0.5% from acquisitions) and adjusted EPS of $12.00–$12.15 (up ~8%–9%, or ~9%–10% excluding currency); currency is expected to be neutral to Q3 sales and a ~1% headwind to Q3 EPS. Additional 2026 assumptions: total amortization ~$78M (purchased intangibles ~$28M pretax, ≈$1.07), interest expense ~$67M, other income ~$24M, effective tax rate ~19%, free cash flow ~ $900M (≈6% growth per share), and share repurchases increased to $875M for the year (vs. $825M annualized in H1).Mettler-Toledo Financial Statement Overview
Summary
Income Statement
88
Very Positive
Balance Sheet
52
Neutral
Cash Flow
86
Very Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.13B | 4.03B | 3.87B | 3.79B | 3.92B | 3.72B |
| Gross Profit | 2.45B | 2.32B | 2.25B | 2.17B | 2.24B | 2.11B |
| EBITDA | 1.30B | 1.23B | 1.22B | 1.18B | 1.24B | 1.10B |
| Net Income | 905.61M | 869.19M | 863.14M | 788.78M | 872.50M | 768.99M |
Balance Sheet | ||||||
| Total Assets | 3.67B | 3.71B | 3.24B | 3.36B | 3.49B | 3.33B |
| Cash, Cash Equivalents and Short-Term Investments | 51.38M | 66.89M | 59.36M | 69.81M | 95.97M | 98.56M |
| Total Debt | 2.11B | 2.34B | 2.13B | 2.20B | 2.13B | 1.80B |
| Total Liabilities | 3.66B | 3.74B | 3.37B | 3.51B | 3.47B | 3.16B |
| Stockholders Equity | 12.82M | -23.64M | -126.89M | -149.94M | 24.79M | 171.42M |
Cash Flow | ||||||
| Free Cash Flow | 863.97M | 848.65M | 864.45M | 860.55M | 737.83M | 801.25M |
| Operating Cash Flow | 975.17M | 955.77M | 968.35M | 965.87M | 859.07M | 908.83M |
| Investing Cash Flow | -172.61M | -193.87M | -119.46M | -131.69M | -139.40M | -314.11M |
| Financing Cash Flow | -817.11M | -755.17M | -855.98M | -859.59M | -716.04M | -590.55M |
Mettler-Toledo Technical Analysis
Positive
1327.18
Price Trends
1264.94
Positive
1245.17
Positive
1320.91
Positive
Market Momentum
48.00
Negative
68.65
Neutral
65.17
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MTD, the sentiment is Positive. The current price of 1327.18 is below the 20-day moving average (MA) of 1357.85, above the 50-day MA of 1264.94, and above the 200-day MA of 1320.91, indicating a bullish trend. The MACD of 48.00 indicates Negative momentum. The RSI at 68.65 is Neutral, neither overbought nor oversold. The STOCH value of 65.17 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MTD.
Mettler-Toledo Risk Analysis
Mettler-Toledo disclosed 29 risk factors in its most recent earnings report. Mettler-Toledo reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Mettler-Toledo Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $213.42B | 30.84 | 13.35% | 0.32% | 7.23% | 7.47% | |
75 Outperform | $28.62B | 31.80 | -1199.91% | ― | 6.91% | 12.43% | |
74 Outperform | $25.72B | 24.42 | 14.49% | 1.46% | 9.87% | 12.51% | |
72 Outperform | $137.07B | 34.53 | 7.66% | 0.75% | 4.56% | 19.34% | |
71 Outperform | $39.08B | 27.73 | 20.84% | 0.59% | 9.11% | 22.77% | |
61 Neutral | $37.05B | 47.88 | 1.88% | ― | 26.39% | -28.79% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
MTD
Mettler-Toledo
1,429.46
172.97
13.77%
A
Agilent
145.97
32.75
28.92%
DHR
Danaher
204.76
6.46
3.26%
DGX
Quest Diagnostics
238.35
63.07
35.98%
TMO
Thermo Fisher
594.00
133.29
28.93%
WAT
Waters
406.86
127.57
45.68%
Mettler-Toledo Corporate Events
Executive/Board Changes
Mettler-Toledo Appoints Natalia Shuman to Board of Directors
Positive
Aug 3, 2026
On July 30, 2026, Mettler-Toledo’s board appointed Natalia Shuman as an independent director, effective August 3, 2026, and expanded the board from nine to ten members to accommodate her addition. Her director compensation will match that of...
Executive/Board ChangesShareholder Meetings
Mettler-Toledo Shareholders Approve Directors and Executive Pay
Positive
May 11, 2026
At its annual meeting on May 7, 2026, Mettler-Toledo International Inc. reported that 18,545,318 of 20,248,505 eligible shares were represented, establishing a quorum for stockholder voting. Shareholders elected nine directors to one-year terms, w...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.